Drugs / RGB-02
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03146988 | Apr → Sep 2017 | — | Gedeon Richter Plc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RGB-02 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03146988 ↗ |
| Route | Subcutaneous | “administered as subcutaneous injection” NCT03146988 ↗ |